Form 4 for CVS CVS Health
Accepted 2023-11-17 00:00:00 ET · period of report 2023-11-15 · accession 0001127602-23-027832 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-17 | 2023-11-15 | CVS | Finucane Anne A. | Dir | A - Grant | $69.13 | +1,925 | 10.7K | +22% | +$133.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-15 | A | A | 1,925 | $69.13 | 10,682.25 | D | — | — |